Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer

Variability of performance status assessment between patients with hematologic malignancies and their physicians

(2017) Alexis D. Leal et al.   LEUKEMIA & LYMPHOMA

Validation of a screening test for elderly patients in oncology

(2017) P. Soubeyran et al.   JOURNAL OF CLINICAL ONCOLOGY

Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non–Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study

(2016) Romain Corre et al.   JOURNAL OF CLINICAL ONCOLOGY

Unknown

(2016)   STATISTICS IN MEDICINE

The prevalence and outcomes of frailty in older cancer patients: a systematic review

(2014) C. Handforth et al.   ANNALS OF ONCOLOGY

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Prospective, Randomized, Multicenter, Phase III Study of Fluorouracil, Leucovorin, and Irinotecan Versus Epirubicin, Cisplatin, and Capecitabine in Advanced Gastric Adenocarcinoma: A French Intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) Study

(2014) Rosine Guimbaud et al.   JOURNAL OF CLINICAL ONCOLOGY

End Points and Trial Design in Geriatric Oncology Research: A Joint European Organisation for Research and Treatment of Cancer–Alliance for Clinical Trials in Oncology–International Society of Geriatric Oncology Position Article

(2013) Hans Wildiers et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical trial design in older adults with cancer—The need for new paradigms

(2012) Stuart M. Lichtman   Journal of Geriatric Oncology

EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors

(2011) A. G. Pallis et al.   ANNALS OF ONCOLOGY

Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study

(2011) Arti Hurria et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial

(2011) Matthew T Seymour et al.   LANCET

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie

(2008) S.-E. Al-Batran et al.   ANNALS OF ONCOLOGY

Irinotecan/Fluorouracil Combination in First-Line Therapy of Older and Younger Patients With Metastatic Colorectal Cancer: Combined Analysis of 2,691 Patients in Randomized Controlled Trials

(2008) Gunnar Folprecht et al.   JOURNAL OF CLINICAL ONCOLOGY

Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer

(2008) David Cunningham et al.   NEW ENGLAND JOURNAL OF MEDICINE